New developments in the pharmacological treatment of anxiety

Human Psychopharmacology

Volumn 14, Issue SUPPL. 1, 1999, Pages

  Leonard, B E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

5HT1A agonists; 5HT2A antagonists; 5HT3 antagonists; Antihistamines; Cholecystokinin antagonists; GABA benzodiazepine receptors

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BRETAZENIL; BUSPIRONE; CHLORIDE ION; CLOBAZAM; DEVAZEPIDE; DIAZEPAM; ETAZOLATE; ETIZOLAM; GEPIRONE; HYDROXYZINE; INDOSINE; IPSAPIRONE; KETANSERIN; ONDANSETRON; PARTIAL AGONIST; SURICLONE; TANDOSPIRONE; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ANXIETY NEUROSIS; CHEMICAL STRUCTURE; CHLORIDE CONDUCTANCE; CONFERENCE PAPER; DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; DRUG EFFICACY; MEMORY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PANIC; PRIORITY JOURNAL; SEDATION; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

EID: 0032745202     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199908)14:1+3.0.CO;2-G     Document Type: Conference Paper

References (36)

1. Barranco, S. F. and Wagner, B. (1977). Pharmacological properties of hydroxyzine. Current Therapeutic Research, 22 (NI, July, Section 2).
2. Benke, D., Martens, S., Trzeciak, A., Gillessen, D. and Mohler, H. (1991). GABA A receptors display association of gamma 2-subunit with alpha 1 and beta 2/3 subunits. Journal of Biological Chemistry, 266, 4478-4483.
3. Blier, P., DeMontigny, C. and Chaput, Y. (1987). Modification of the serotonin system by antidepressants: implication for the therapeutic response in major depression. Journal of Clinical Psychopharmacology, 7 (Suppl. 6), 245-355.
4. Bradwejn, J. and Koszyychi, D. (1994). Imipramine antagonism of panicogenic effects of cholecystokin tetrapeptide in panic disorder patients. American Journal of Psychiatry, 151, 261-263.
5. Bradwejn et al. (1991).
6. Braestrup, C. and Nielsen, M. (1983). Benzodiazepine receptors. In Handbook of Psychopharmacology, Vol. 27, Iverson, L. L., Iverson, S. D. and Snyder, S. H. (Eds), Plenum Press, New York, pp. 285-384.
7. Braestrup, C. and Squires, R. F. (1978). Pharmacological characterisation of benzodiazepine receptors in the brain. European Journal of Pharmacology, 48, 263-270.
8. Costa, E., Guidotti, A., Mao, C. C. and Suria, A. (1975). New conceots on the mechanism of action of benzodiazepines. Life Sciences, 17, 167-186.
9. Delini-Stula, A. (1992). Bretazeil: clinical experience. Neuroscience Facts, 3, 72.
10. DeMontigny, C. (1989). Cholecystokinin tetrapeptide induced panic-like attacks in healthy volunteers. Archives General Psychiatry, 46, 511-517.
11. Ferre, S., Fuxe, K., Von Enler, G., Johansson, B. and Fredholm, B. B. (1992). Adenosine-sopamine interactions in the brain. Neuroscience, 51, 501-512.
12. Ferrier, M., Darcis, T., Martens, J., Burtin, B. and Deram, P. (1995). A multicentre double-blind placebo controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalised anxiety. Human Psychopharmacology, 10, 181-187.
13. Fredholm, B. B. and Dunwiddie, T. V. (1988). How does adenosine inhibit transmitter release? Trends in Pharmacological Sciences, 9, 130-134.
14. Goldberg, H. L. and Finnerty, R. J. (1979). The comparative efficacy of buspirone and diazepam in the treatment of anxiety. American Journal of Psychiatry, 136, 1184-1187.
15. Haefely, W., Kulcsar, A., Moehler, H., Pierri, L., Polc, P. and Schaffner, R. (1975). Possible involvement of GABA in the central actions of benzodiazepines. In Mechanism of Action of Benzodiazepines, Costa, E. and Greengard, P. (Eds), Raven Press, New York, pp. 131-152.
16. Haefely, W., Kyburz, E., Gerecke, M. and Mohler, H. (1985). Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationship of their agonists and antagonists. Advances in Drug Research, 124, 165-322.
17. Haefely, W., Martin, J. R. and Schoch, P. (1990). Novel anxiolytics acting as partial agonists at benzodiazepine receptors. Trends in Pharmacological Science, 11, 452-456.
18. Ladre, M. H. (1989). Benzodiazepines in profile. Prescribers Journal, 29, 12-18.
19. Leonard, B. E. (1996). Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychotherapy and Psychosomatic, 65, 66-75.
20. Lopez, F., Miller, G., Greenblatt, D. J., Chesley, S., Schatzki, A. and Shader, R. I. (1990). Chronic administration of benzodiazepines. V. Rapid onset of behavioural and neurochernical alterations after discontinuation of alprazolam. Neuropharmacology, 29, 237-241.
21. McDonagh, C. J., Goodman, W. K. and Leckman, J. F. (1993). Limited therapeutic effect of addition of buspirone in fluvoxamine refractory OCD. American Journal of Psychiatry, 50, 647-649.
22. Millington, W. R., Muller, G. P. and Lavigne, G. J. (1992). Cholecystokinin Type A and B receptor antagonists produce opposing effects on CCK-stimulated bendorphin secretion from the rat pituitary. Journal of Pharmacology and Experimental Therapeutics, 261, 454-461.
23. Mohler, H. and Fritschy, J.-M. (1992). Expression of GABA-A receptor subtypes. Neuroscience Facts, 3, 70-71.
24. Munjack, D. J., Brun, S. J. and Baltazar, P. L. (1991). A pilot study of buspirone in the treatment of social phobia. Journal of Anxiety Disorders, 5, 87-98.
25. Natens, J. (1992). Present position of hydroxyzine and related ataractic drugs in the treatment of anxiety. Molecular pharmacology. Int. Acad. Biomed. Drug Res. Basel, Karger, 3, 78-84.
26. Richards, G., Schoch, P. and Haefely, W. (1991). Benzodiazepine receptors: new vistas. Seminar in the Neurosciences, 3, 191-203.
27. Rickels, K. (1987). Anti anxiety therapy: potential value of long-term treatments. Journal of Clinical Psychiatry, 48(Suppl.), 7-11.
28. 1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Progress in Neuropsychopharmacology and Biological Psychiatry, 17, 87-104.
29. Sheehan, D. V., Raj, A. B., Sheehan, K. H. and Soto, S. (1990). Is buspirone effective for panic disorder? Journal of Clinical Psychopharmacology, 10, 3-11.
30. Ticku, M. K. (1991). Drug modulation of GABA A mediated transmission. Seminars in the Neurosciences, 3, 211-219.
31. Trulson, M. E., Prenssler, D. W. and Gailyn, A. (1982). Raphe unit activity in freely moving cats: effects of benzodiazepines. Neuropharmacology, 21, 1045-1050.
32. Uhlenhuth, E. H. (1988). Risks and benefits of long-term benzodiazepines. Journal of Clinical Psychopharmacology, 8, 161-167.
33. Verge, D., Duval, G. and Mareinkiewicz, M. (1986). Quantitative autoradiography of subtype 5HT receptor subtypes in the brain of control or 5,7-DHT treated rats. Journal of Neuroscience, 6, 3474-3482.
34. Webb, R. L., Sills, M. A., Choran, J. P., Peppard, J. V. and Francis, J. E. (1993). Development of tolerance to the antihypertensive effects of highly selective adenosine A2 agonists upon chronic administration. Journal of Pharmacology and Experimental Therapeutics, 267, 287-295.
35. Westerberg, V. S. and Geiger, J. D. (1987). Central effects of adenosine analogs on stress-induced gastric ulcer formation. Life Science, 41, 2201-2205.
36. Zifa, E. and Fillin, G. (1992). 5-Hydroxytryptamine receptors. Pharmacological Reviews, 44, 406-458.